Abstract The Practice Guidelines Committee of the American Society for Transplantation and
Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to …

Human cytomegalovirus (CMV) infection, which is one of the most common complications in
transplant recipients, increases the risk of graft loss and rejection. Laboratory strategies for …

Infections are leading causes of morbidity/mortality following solid organ transplantation
(SOT) and cytomegalovirus (CMV) is among the most frequent pathogens, causing a …

The incidence of infectious complications, compared with the general population and the pre-
transplant status of the recipient, increases substantially following kidney transplantation …

Risk stratification for cytomegalovirus (CMV) infection after kidney transplantation (KT)
remains to be determined. Since endosomal toll-like receptors (TLRs) are involved in viral …

Viral infections and reactivations are major causes of morbidity and mortality after
hematopoietic stem cell (HSCT) and solid organ transplantation (SOT) as well as in patients …

Cytomegalovirus (CMV) viremia continues to cause significant morbidity and mortality in
kidney transplant patients with clinical complications including organ rejection and death …

Cytomegalovirus (CMV) is a major cause of infection-related morbidity and mortality in
kidney transplantation. The most significant risk for developing CMV infection after transplant …

Background Malignancy is a major cause of morbidity and mortality in transplant recipients.
Identification of those at highest risk could facilitate pre-emptive intervention such as …

Cytomegalovirus (CMV)-seropositive kidney transplant recipients (KTRs) with detectable
CMV-specific cell-mediated immunity according to the QuantiFERON-CMV assay (QTF …